Kali iodatum
POTASSIUM IODIDE
ORAL
HUMAN OTC DRUG
Kali iodatum is an FDA drug label for the active ingredient POTASSIUM IODIDE manufactured by Boiron administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231113.
- Generic name
- POTASSIUM IODIDE
- Manufacturer
- Boiron
- Product type
- HUMAN OTC DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 0220-2800
- Application
- N/A
- Label effective
- 20231113
Active ingredients
Kali iodatum 9C (**contains 0.443 mg of the active ingredient per pellet)
Indications & Usage
Frontal Sinus Pain With Runny Nose, Worse At Night*
Dosage & Administration
Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
Contraindications
Not available.
Warnings
Not available.
Adverse Reactions
Not available.